CN Stock MarketDetailed Quotes

688105 Nanjing Vazyme Biotech

Watchlist
  • 18.82
  • -0.26-1.36%
Market Closed Sep 10 15:00 CST
7.53BMarket Cap285.15P/E (TTM)

Nanjing Vazyme Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
13.70%649.27M
-0.21%301.57M
-63.97%1.29B
-62.29%869.3M
-64.74%571.04M
-69.02%302.19M
90.99%3.57B
78.87%2.31B
96.20%1.62B
80.07%975.34M
Operating revenue
13.70%649.27M
-0.21%301.57M
-63.97%1.29B
-62.29%869.3M
-64.74%571.04M
-69.02%302.19M
90.99%3.57B
78.87%2.31B
96.20%1.62B
80.07%975.34M
Total operating cost
-0.14%665.65M
-9.55%317.25M
-39.78%1.4B
-30.49%989.19M
-25.39%666.55M
-23.75%350.73M
113.63%2.33B
120.38%1.42B
140.06%893.35M
200.57%459.99M
Operating cost
20.03%189.95M
-7.84%87.26M
-66.45%372.56M
-59.64%252.69M
-62.23%158.25M
-61.53%94.68M
216.52%1.11B
265.58%626.12M
284.99%419.02M
501.26%246.09M
Operating tax surcharges
128.49%6.16M
132.43%2.07M
-87.46%2.42M
-68.44%3.16M
-61.26%2.7M
-75.98%890.6K
173.57%19.28M
77.90%10.01M
83.91%6.96M
47.69%3.71M
Operating expense
-4.15%217.66M
-0.14%103.03M
-9.52%472.69M
-4.63%329.5M
11.57%227.08M
14.75%103.18M
63.52%522.4M
71.46%345.48M
96.46%203.53M
88.09%89.92M
Administration expense
-6.49%108.52M
-18.73%53.87M
-20.36%236.19M
-4.48%173M
3.43%116.06M
35.07%66.29M
64.92%296.57M
55.24%181.12M
61.68%112.21M
106.51%49.08M
Financial expense
109.32%878.24K
-67.02%259.3K
-28.90%-19.33M
-61.88%-15.53M
-76.43%-9.42M
1,934.82%786.17K
-582.82%-15M
-442.29%-9.59M
-368.17%-5.34M
123.49%38.64K
-Interest expense (Financial expense)
2.12%15.58M
77.83%8.96M
181.08%35.07M
263.82%27.52M
212.07%15.26M
41.98%5.04M
222.90%12.48M
191.26%7.57M
238.84%4.89M
826.46%3.55M
-Interest Income (Financial expense)
14.87%-16.31M
-47.11%-9.5M
-124.80%-52.36M
-136.61%-38.76M
-77.98%-19.16M
0.61%-6.46M
-634.62%-23.29M
-2,926.24%-16.38M
-2,986.99%-10.77M
-2,483.33%-6.5M
Research and development
-17.11%142.48M
-16.66%70.76M
-14.51%338.62M
-8.71%246.38M
9.50%171.89M
19.32%84.91M
71.98%396.11M
82.53%269.9M
85.73%156.97M
86.32%71.16M
Credit Impairment Loss
-138.73%-8.19M
-113.33%-1.64M
104.79%4.5M
189.86%20.84M
250.54%21.15M
207.37%12.28M
-631.16%-94.05M
-77.00%-23.19M
-271.78%-14.05M
-297.89%-11.44M
Asset Impairment Loss
84.53%-11.79M
85.65%-8.7M
73.06%-142.32M
2.08%-82.41M
-48.34%-76.25M
-198.29%-60.66M
-1,250.09%-528.23M
-184.06%-84.16M
-186.66%-51.41M
-403.07%-20.34M
Other net revenue
Fair value change income
6.44%27.74M
18.27%16.6M
-6.23%43.04M
41.35%33.12M
158.93%26.06M
56.28%14.03M
687.35%45.9M
259.53%23.43M
172.68%10.06M
134.16%8.98M
Invest income
-30.68%1.69M
-74.39%529.19K
-81.29%7.88M
-82.97%6.83M
-90.38%2.43M
-77.84%2.07M
75.68%42.12M
167.72%40.08M
183.62%25.31M
145.28%9.33M
-Including: Investment income associates
----
----
----
----
----
----
-41.70%-2.15M
---2.31M
-579.35%-1.8M
---671.46K
Asset deal income
-264.79%-1.13M
678.81%324.61K
2,726.13%5.67M
1,078.83%5.5M
20,319.31%683.78K
-229.55%-56.08K
-2,083.81%-215.72K
1,536.88%466.54K
-105.42%-3.38K
184.32%43.29K
Other revenue
-65.67%5.01M
-80.34%2.76M
663.71%98.2M
391.15%38.73M
114.03%14.61M
337.69%14.05M
-15.96%12.86M
94.03%7.89M
81.66%6.82M
40.93%3.21M
Operating profit
97.15%-3.05M
91.31%-5.8M
-113.96%-100.18M
-111.49%-97.29M
-115.19%-106.83M
-113.23%-66.83M
-6.96%717.49M
35.29%846.49M
56.89%703.1M
29.01%505.13M
Add:Non operating Income
-69.43%328.87K
-66.48%93.69K
-21.35%1.08M
15.52%987.47K
59.70%1.08M
-22.24%279.53K
494.97%1.37M
485.49%854.82K
361.45%673.73K
1,697.51%359.5K
Less:Non operating expense
-307.15%-2.49M
-332.01%-3.35M
-84.83%16.61M
1,330.93%11.94M
106.62%1.2M
256.14%1.44M
1,481.24%109.47M
-64.32%834.51K
22.71%581.79K
34.14%404.94K
Total profit
99.79%-229.91K
96.52%-2.36M
-118.99%-115.71M
-112.79%-108.25M
-115.21%-106.95M
-113.46%-67.99M
-20.28%609.39M
35.76%846.51M
57.03%703.19M
29.09%505.09M
Less:Income tax cost
37.77%-15.53M
56.85%-7.24M
-369.80%-42.85M
-131.47%-30.53M
-127.97%-24.97M
-122.76%-16.78M
-81.56%15.88M
32.36%97.02M
59.49%89.25M
34.66%73.73M
Net profit
FLtoP15.3M
FLtoP4.88M
SL-72.86M
SL-77.72M
SL-81.99M
SL-51.21M
-12.50%593.51M
36.22%749.5M
56.67%613.94M
28.18%431.36M
Net profit from continuing operation
118.67%15.3M
109.52%4.88M
-112.28%-72.86M
-110.37%-77.72M
-113.35%-81.99M
-111.87%-51.21M
-12.50%593.51M
36.22%749.5M
56.67%613.94M
28.18%431.36M
Less:Minority Profit
4.57%-854.49K
41.72%-341.1K
-157.99%-1.91M
-458.41%-1.33M
-42,844,266.03%-895.45K
-31,636,538.38%-585.28K
-923,357,750.00%-738.69K
---237.63K
---2.09
---1.85
Net profit of parent company owners
119.93%16.16M
110.30%5.22M
-111.94%-70.96M
-110.19%-76.39M
-113.21%-81.09M
-111.74%-50.62M
-12.39%594.25M
36.26%749.74M
56.67%613.94M
28.18%431.36M
Earning per share
Basic earning per share
120.00%0.04
107.69%0.01
-112.08%-0.18
-110.16%-0.19
-113.07%-0.2
-112.04%-0.13
-20.32%1.49
22.22%1.87
40.37%1.53
16.13%1.08
Diluted earning per share
120.00%0.04
107.69%0.01
-112.08%-0.18
-110.16%-0.19
-113.07%-0.2
-112.04%-0.13
-20.32%1.49
22.22%1.87
40.37%1.53
16.13%1.08
Other composite income
79.08%-703.82K
-116.69%-239.32K
-1.72M
-3.11M
-3.36M
1.43M
Other composite income of parent company owners
79.07%-703.87K
-116.69%-239.32K
---1.72M
---3.11M
---3.36M
--1.43M
----
----
----
----
Other composite income of minority owners
266.06%48.09
14.74%-1.62
---1.97
---14.75
---28.96
---1.9
----
----
----
----
Total composite income
117.11%14.6M
109.31%4.64M
-112.57%-74.58M
-110.78%-80.83M
-113.90%-85.35M
-111.54%-49.77M
-12.50%593.51M
36.22%749.5M
56.67%613.94M
28.18%431.36M
Total composite income of parent company owners
118.30%15.46M
110.12%4.98M
-112.23%-72.68M
-110.60%-79.5M
-113.76%-84.46M
-111.40%-49.19M
-12.39%594.25M
36.26%749.74M
56.67%613.94M
28.18%431.36M
Total composite income of minority owners
4.58%-854.44K
41.72%-341.11K
-157.99%-1.91M
-458.42%-1.33M
-42,845,651.67%-895.48K
-31,636,641.08%-585.28K
-923,357,750.00%-738.69K
---237.63K
---2.09
---1.85
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 13.70%649.27M-0.21%301.57M-63.97%1.29B-62.29%869.3M-64.74%571.04M-69.02%302.19M90.99%3.57B78.87%2.31B96.20%1.62B80.07%975.34M
Operating revenue 13.70%649.27M-0.21%301.57M-63.97%1.29B-62.29%869.3M-64.74%571.04M-69.02%302.19M90.99%3.57B78.87%2.31B96.20%1.62B80.07%975.34M
Total operating cost -0.14%665.65M-9.55%317.25M-39.78%1.4B-30.49%989.19M-25.39%666.55M-23.75%350.73M113.63%2.33B120.38%1.42B140.06%893.35M200.57%459.99M
Operating cost 20.03%189.95M-7.84%87.26M-66.45%372.56M-59.64%252.69M-62.23%158.25M-61.53%94.68M216.52%1.11B265.58%626.12M284.99%419.02M501.26%246.09M
Operating tax surcharges 128.49%6.16M132.43%2.07M-87.46%2.42M-68.44%3.16M-61.26%2.7M-75.98%890.6K173.57%19.28M77.90%10.01M83.91%6.96M47.69%3.71M
Operating expense -4.15%217.66M-0.14%103.03M-9.52%472.69M-4.63%329.5M11.57%227.08M14.75%103.18M63.52%522.4M71.46%345.48M96.46%203.53M88.09%89.92M
Administration expense -6.49%108.52M-18.73%53.87M-20.36%236.19M-4.48%173M3.43%116.06M35.07%66.29M64.92%296.57M55.24%181.12M61.68%112.21M106.51%49.08M
Financial expense 109.32%878.24K-67.02%259.3K-28.90%-19.33M-61.88%-15.53M-76.43%-9.42M1,934.82%786.17K-582.82%-15M-442.29%-9.59M-368.17%-5.34M123.49%38.64K
-Interest expense (Financial expense) 2.12%15.58M77.83%8.96M181.08%35.07M263.82%27.52M212.07%15.26M41.98%5.04M222.90%12.48M191.26%7.57M238.84%4.89M826.46%3.55M
-Interest Income (Financial expense) 14.87%-16.31M-47.11%-9.5M-124.80%-52.36M-136.61%-38.76M-77.98%-19.16M0.61%-6.46M-634.62%-23.29M-2,926.24%-16.38M-2,986.99%-10.77M-2,483.33%-6.5M
Research and development -17.11%142.48M-16.66%70.76M-14.51%338.62M-8.71%246.38M9.50%171.89M19.32%84.91M71.98%396.11M82.53%269.9M85.73%156.97M86.32%71.16M
Credit Impairment Loss -138.73%-8.19M-113.33%-1.64M104.79%4.5M189.86%20.84M250.54%21.15M207.37%12.28M-631.16%-94.05M-77.00%-23.19M-271.78%-14.05M-297.89%-11.44M
Asset Impairment Loss 84.53%-11.79M85.65%-8.7M73.06%-142.32M2.08%-82.41M-48.34%-76.25M-198.29%-60.66M-1,250.09%-528.23M-184.06%-84.16M-186.66%-51.41M-403.07%-20.34M
Other net revenue
Fair value change income 6.44%27.74M18.27%16.6M-6.23%43.04M41.35%33.12M158.93%26.06M56.28%14.03M687.35%45.9M259.53%23.43M172.68%10.06M134.16%8.98M
Invest income -30.68%1.69M-74.39%529.19K-81.29%7.88M-82.97%6.83M-90.38%2.43M-77.84%2.07M75.68%42.12M167.72%40.08M183.62%25.31M145.28%9.33M
-Including: Investment income associates -------------------------41.70%-2.15M---2.31M-579.35%-1.8M---671.46K
Asset deal income -264.79%-1.13M678.81%324.61K2,726.13%5.67M1,078.83%5.5M20,319.31%683.78K-229.55%-56.08K-2,083.81%-215.72K1,536.88%466.54K-105.42%-3.38K184.32%43.29K
Other revenue -65.67%5.01M-80.34%2.76M663.71%98.2M391.15%38.73M114.03%14.61M337.69%14.05M-15.96%12.86M94.03%7.89M81.66%6.82M40.93%3.21M
Operating profit 97.15%-3.05M91.31%-5.8M-113.96%-100.18M-111.49%-97.29M-115.19%-106.83M-113.23%-66.83M-6.96%717.49M35.29%846.49M56.89%703.1M29.01%505.13M
Add:Non operating Income -69.43%328.87K-66.48%93.69K-21.35%1.08M15.52%987.47K59.70%1.08M-22.24%279.53K494.97%1.37M485.49%854.82K361.45%673.73K1,697.51%359.5K
Less:Non operating expense -307.15%-2.49M-332.01%-3.35M-84.83%16.61M1,330.93%11.94M106.62%1.2M256.14%1.44M1,481.24%109.47M-64.32%834.51K22.71%581.79K34.14%404.94K
Total profit 99.79%-229.91K96.52%-2.36M-118.99%-115.71M-112.79%-108.25M-115.21%-106.95M-113.46%-67.99M-20.28%609.39M35.76%846.51M57.03%703.19M29.09%505.09M
Less:Income tax cost 37.77%-15.53M56.85%-7.24M-369.80%-42.85M-131.47%-30.53M-127.97%-24.97M-122.76%-16.78M-81.56%15.88M32.36%97.02M59.49%89.25M34.66%73.73M
Net profit FLtoP15.3MFLtoP4.88MSL-72.86MSL-77.72MSL-81.99MSL-51.21M-12.50%593.51M36.22%749.5M56.67%613.94M28.18%431.36M
Net profit from continuing operation 118.67%15.3M109.52%4.88M-112.28%-72.86M-110.37%-77.72M-113.35%-81.99M-111.87%-51.21M-12.50%593.51M36.22%749.5M56.67%613.94M28.18%431.36M
Less:Minority Profit 4.57%-854.49K41.72%-341.1K-157.99%-1.91M-458.41%-1.33M-42,844,266.03%-895.45K-31,636,538.38%-585.28K-923,357,750.00%-738.69K---237.63K---2.09---1.85
Net profit of parent company owners 119.93%16.16M110.30%5.22M-111.94%-70.96M-110.19%-76.39M-113.21%-81.09M-111.74%-50.62M-12.39%594.25M36.26%749.74M56.67%613.94M28.18%431.36M
Earning per share
Basic earning per share 120.00%0.04107.69%0.01-112.08%-0.18-110.16%-0.19-113.07%-0.2-112.04%-0.13-20.32%1.4922.22%1.8740.37%1.5316.13%1.08
Diluted earning per share 120.00%0.04107.69%0.01-112.08%-0.18-110.16%-0.19-113.07%-0.2-112.04%-0.13-20.32%1.4922.22%1.8740.37%1.5316.13%1.08
Other composite income 79.08%-703.82K-116.69%-239.32K-1.72M-3.11M-3.36M1.43M
Other composite income of parent company owners 79.07%-703.87K-116.69%-239.32K---1.72M---3.11M---3.36M--1.43M----------------
Other composite income of minority owners 266.06%48.0914.74%-1.62---1.97---14.75---28.96---1.9----------------
Total composite income 117.11%14.6M109.31%4.64M-112.57%-74.58M-110.78%-80.83M-113.90%-85.35M-111.54%-49.77M-12.50%593.51M36.22%749.5M56.67%613.94M28.18%431.36M
Total composite income of parent company owners 118.30%15.46M110.12%4.98M-112.23%-72.68M-110.60%-79.5M-113.76%-84.46M-111.40%-49.19M-12.39%594.25M36.26%749.74M56.67%613.94M28.18%431.36M
Total composite income of minority owners 4.58%-854.44K41.72%-341.11K-157.99%-1.91M-458.42%-1.33M-42,845,651.67%-895.48K-31,636,641.08%-585.28K-923,357,750.00%-738.69K---237.63K---2.09---1.85
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg